SINGAPORE – EUDA Health Holdings Limited (NASDAQ:EUDA), a Singapore-based non-invasive healthcare provider with a market capitalization of $104 million, announced Monday it will integrate the QB utility token into its digital health and rewards platform. The stock has surged nearly 24% over the past week on the news, showing significant momentum.
The QB token is being created and issued by QB Limited, a Hong Kong company that also serves as the exclusive distributor of EUDA Helixe supplements in Hong Kong and Macau.
According to the company’s press release, customers and agents within the EUDA ecosystem will be able to earn and redeem QB tokens for healthcare offerings including Bioenergy Capsule treatments, Euda Helixe supplements, and selected stem cell services.
EUDA will receive QB tokens solely in exchange for products and services provided to QB Limited, with no monetary transactions involved. The company stated that all activity will be traceable on the blockchain within the QB ecosystem.
The QB utility token has been built on Binance Smart Chain, enabling swaps with USD1 stablecoins developed by World Liberty Financial Inc. The USD1 stablecoin is described as being 1:1 redeemable with the US dollar and backed by reserves held in treasury bills, cash deposits, and other cash equivalents.
“Once launched, the QB utility token will unify our healthcare and rewards ecosystem under a single digital framework,” said Alfred Lim, CEO of EUDA, in the press release.
EUDA Health operates in Singapore, Malaysia, and China, focusing on non-invasive and preventive healthcare with emphasis on longevity services. The company aims to address healthcare needs in a region experiencing significant demographic shifts with an aging population.
In other recent news, EUDA Health Holdings Limited announced plans to launch a healthcare cryptocurrency called QB in January 2026. The digital currency will be part of an integrated digital health and rewards platform. Additionally, EUDA Health has secured a $100,000 warrant agreement with Streeterville Capital, LLC, allowing for the purchase of up to 2 million newly issued ordinary shares at $6.00 per share. This follows another securities purchase agreement for a $100,000 convertible warrant, which is immediately exercisable and valid for 90 days, with potential extensions. In a recent board change, Huang Bo was appointed as an independent director, replacing Wong Kong Yew, who resigned without any disputes with the company. Furthermore, EUDA Health’s subsidiary, CK Health Plus Sdn. Bhd., is expanding into the Indian wellness market through a partnership with SafeRock India Private Limited. This strategic move aims to establish a presence in major Indian cities such as Mumbai, Bangalore, and Karnataka.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.